Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications

Detalles Bibliográficos
Autores principales: Willmer, Tarryn, Johnson, Rabia, Louw, Johan, Pheiffer, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349824/
https://www.ncbi.nlm.nih.gov/pubmed/30723457
http://dx.doi.org/10.3389/fendo.2019.00001
_version_ 1783390325696364544
author Willmer, Tarryn
Johnson, Rabia
Louw, Johan
Pheiffer, Carmen
author_facet Willmer, Tarryn
Johnson, Rabia
Louw, Johan
Pheiffer, Carmen
author_sort Willmer, Tarryn
collection PubMed
description
format Online
Article
Text
id pubmed-6349824
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63498242019-02-05 Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications Willmer, Tarryn Johnson, Rabia Louw, Johan Pheiffer, Carmen Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2019-01-22 /pmc/articles/PMC6349824/ /pubmed/30723457 http://dx.doi.org/10.3389/fendo.2019.00001 Text en Copyright © 2019 Willmer, Johnson, Louw and Pheiffer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Willmer, Tarryn
Johnson, Rabia
Louw, Johan
Pheiffer, Carmen
Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title_full Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title_fullStr Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title_full_unstemmed Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title_short Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
title_sort corrigendum: blood-based dna methylation biomarkers for type 2 diabetes: potential for clinical applications
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349824/
https://www.ncbi.nlm.nih.gov/pubmed/30723457
http://dx.doi.org/10.3389/fendo.2019.00001
work_keys_str_mv AT willmertarryn corrigendumbloodbaseddnamethylationbiomarkersfortype2diabetespotentialforclinicalapplications
AT johnsonrabia corrigendumbloodbaseddnamethylationbiomarkersfortype2diabetespotentialforclinicalapplications
AT louwjohan corrigendumbloodbaseddnamethylationbiomarkersfortype2diabetespotentialforclinicalapplications
AT pheiffercarmen corrigendumbloodbaseddnamethylationbiomarkersfortype2diabetespotentialforclinicalapplications

Ejemplares similares